APP and Alzheimer disease: Using mass cytometry which allows to investigate changes in microglial proteome, at the single‐cell level, a similar “disease‐associated” microglial phenotype was recently described in aging and AD pathology (APP/PS1 mice; Mrdjen et al, 2018).